This Capricor Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Wall Street analysts revised their ratings for top stocks. Visit benzinga.com/analyst-stock-ratings for all changes, including upgrades and downgrades.
An analyst changed their mind to like Capricor Therapeutics more, and several other stocks got upgraded too. When experts switch to liking a stock, it means they think the company might do better—but their opinion can change again, so watch how the company actually performs.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.